投稿咨詢
Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology.
The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases.
Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans.
Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers
《Biomedicine & Pharmacotherapy》是一本由ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER出版商出版的專業醫學期刊，該刊創刊于1982年，刊期Monthly，該刊已被國際權威數據庫SCIE、SCI收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 2區，小類學科：藥學 1區；醫學：研究與實驗 2區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋醫學：研究與實驗等領域，旨在及時、準確、全面地報道國內外醫學：研究與實驗工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為7.419，平均審稿速度平均2月。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 2區 | PHARMACOLOGY & PHARMACY 藥學 MEDICINE, RESEARCH & EXPERIMENTAL 醫學：研究與實驗 | 1區 2區 | 是 | 否 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q1 | PHARMACOLOGY & PHARMACY | Q1 | 7.419 |
| MEDICINE, RESEARCH & EXPERIMENTAL | Q1 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 7.419 | 78 | 99.60% | 75.99% | 未開放 | 平均2月 |
課題、SCI/EI/SSCI怎么寫？